#DES #DES2026 #Diabetes #Orforglipron #DiabetesEducation #OralGLP1 #Endocrinology #DiabetesCare To view or add a comment, sign in **Is the Future of Obesity Treatment Moving from Injections to Pills?** For years, obesity management has been dominated by injectable GLP-1 receptor agonists such as semaglutide and tirzepatide
Semaglutide has transformed weight management for millions, but the dose your body needs to achieve meaningful results often goes far beyond where treatment begins
Patients should be careful that they are translating the units correctly as some people have injected themselves with too high concentrations of the drug
You may still be eating in a calorie surplus or retaining water
Oeckl et al., 2012), while another found a non-significant trend toward higher CSF cGMP levels in PD patients when compared with controls and higher levels in levodopa-treated PD patients compared with those without levodopa treatment (Navarro et al., 1998)
Its not a traditional skincare step, but it gives my skin a boost of hydration that lasts through the night
